Esophageal Neoplasms Clinical Trials in Houston, Texas
5 recruitingHouston, Texas
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC160 enrolled50 locationsNCT06469944
Recruiting
Phase 1Phase 2
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC210 enrolled44 locationsNCT06445972
Recruiting
Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Breast NeoplasmsCholangiocarcinomaOvarian Neoplasms+4 more
Eli Lilly and Company241 enrolled28 locationsNCT07213791
Recruiting
Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
Esophageal NeoplasmsBrain MetastasesEsophagectomy
Universitaire Ziekenhuizen KU Leuven10,000 enrolled8 locationsNCT04654975
Recruiting
Distribution of Lymph Node Metastases in Esophageal Carcinoma
Lymph Node MetastasesEsophageal Neoplasms
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5,000 enrolled19 locationsNCT03222895